Multiple Myeloma Biologics & Targeted Therapy Market
According to FutureWise analysis the market for multiple myeloma in 2026 is US$ 27.56 billion, and is expected to reach US$ 46.18 billion by 2036 at a CAGR of 5.30%. Market growth is driven by the rising global incidence of hematologic cancers and the adoption of advanced therapies like proteasome inhibitors, immunomodulatory drugs, monoclonal antibodies, and CAR-T cell therapies. Continuous...
0 Kommentare 0 Geteilt 175 Ansichten 0 Bewertungen
Gesponsert

Grow your business at an affordable price

Grow your business at an affordable price

Gesponsert
Gesponsert